Financhill
Back

Standard BioTools Quote, Financials, Valuation and Earnings

Standard BioTools Price Quote

$2.11
+0.08 (+3.94%)
(Updated: September 19, 2024 at 6:55 PM ET)

Standard BioTools Key Stats

Sell
44
Standard BioTools (LAB) is a Sell

Day range:
$1.92 - $2.15
52-week range:
$1.21 - $3.04
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.07
P/B ratio:
1.48%

Volume:
1.2M
Avg. volume:
2.2M
1-year change:
-23.4%
Market cap:
$753.4M
Revenue:
$106.3M
EPS:
$-0.91

How Much Does Standard BioTools Make?

Is Standard BioTools Growing As A Company?

  • What Is Standard BioTools's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.34%
  • What Is Standard BioTools's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Standard BioTools Stock Price Performance

  • Did Standard BioTools Stock Go Up Last Month?
    Standard BioTools share price went up by 14.69% last month
  • Did LAB's Share Price Rise Over The Last Year?
    LAB share price fell by -23.4% over the past 1 year

What Is Standard BioTools 52-Week High & Low?

Standard BioTools Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Standard BioTools?

  • How Much Debt Does Standard BioTools Have?
    Total long term debt quarterly is $55.1M
  • How Much Cash Does Standard BioTools Have?
    Cash and short term investments quarterly total is $394.7M
  • What Is Standard BioTools’s Book Value Per Share?
    Book value per share is 1.37

Is Standard BioTools Cash Flow Positive?

  • What Is LAB Cash Flow From Operations?
    Cash flow from operations (TTM) is -$127M
  • What Is Standard BioTools’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$50.3M
  • What Is Standard BioTools’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $305.3M

Standard BioTools Return On Invested Capital

  • Is Management Doing A Good Job?
    LAB return on invested capital is -59.46%
  • What Is Standard BioTools Return On Assets?
    ROA measures how assets are converting to revenues and is -23.69%
  • What Is LAB Return On Equity?
    ROE is a measure of profitability and is -85.43%

Standard BioTools Earnings Date & Stock Price

Standard BioTools Competitors

Standard BioTools Dividend Yield

Standard BioTools Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -7.6%
Revenue: 34.48% -22.87%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 3.17
Upside from Last Price: 55.99%

Major Shareholders

  • How many LAB shares are owned by institutional investors?
    330.2M LAB shares are owned by institutional investors
  • How many LAB shares are owned by insiders?
    7.4M LAB shares are owned by insiders